The new targets are meaningfully above today’s earnings base, though there is no published FY29 consensus to call a quantified beat. The market already knew an August 5 Investor Day was coming, so the event itself was not new. What is new is management’s FY29 framework: core EBITDA of $1.65–$1.80 billion, 31%–43% above the $1.26 billion trailing base, and free cash flow of $1.38–$1.53 billion, 84%–104% above the current $746 million. That makes this better than a routine strategy presentation, but the targets are a multiyear execution case rather than an upgrade to near-term earnings. (FY29 Financial Targets; Non-GAAP Reconciliations)
| Metric | Current trailing base | FY29 target | What changes |
|---|---|---|---|
| Core EBITDA | $1.259B | $1.650B–$1.800B | +31% to +43% (Non-GAAP Reconciliations; FY29 Financial Targets) |
| Core EBITDA margin | 14.2% | 15.0%–16.0% | +80 to +180 basis points (Non-GAAP Reconciliations; FY29 Financial Targets) |
| Free cash flow | $746M | $1.375B–$1.525B | +84% to +104% (Non-GAAP Reconciliations; FY29 Financial Targets) |
| Free-cash-flow conversion | 59% | 80%–85% | Capital spending is expected to fall materially (Non-GAAP Reconciliations; FY29 Financial Targets) |
| Share-repurchase capacity | $117M previously available | ~$717M available | $600M incremental authorization (Share Repurchase Program) |
The key change is cash generation, not merely a higher EBITDA goal. CMC expects capital expenditures to fall from $513 million on the trailing basis to roughly $275 million by FY29 as the West Virginia mill and other major investments move from buildout to operation. That is the main reason free cash flow is targeted to roughly double even though EBITDA grows by closer to one-third. The framework therefore rests on both earnings growth and a lower-investment cycle. (Free Cash Flow and Capex Outlook; Non-GAAP Reconciliations)
The path is credible enough to support a constructive read, but it is assumption-heavy. Management attributes the improvement to the TAG cost/commercial program, ramping new steel and construction-solutions capacity, precast synergies, and a more favorable product mix. TAG is targeted to exceed $350 million of gross annual EBITDA benefits by the end of FY27, while precast integrations carry $30 million–$40 million of targeted annual synergies by year three. But the FY29 range assumes mid-cycle conditions; its low end explicitly assumes a 25% tariff environment, and some portfolio-mix goals are labeled aspirational and include inorganic growth. (TAG Program; Precast Integration Synergies; FY29 Core EBITDA Bridge; FY29 Financial Targets)
The larger buyback adds a tangible capital-return backstop, but it is authorization rather than a commitment. The board added $600 million, lifting unused capacity to about $717 million after $733 million had already been repurchased since 2021. That is substantial relative to the company’s stated ~$7.6 billion market capitalization, but management retains full discretion over timing and amount, while also targeting net leverage below 2.0x following its recent precast acquisitions. (Share Repurchase Program; Balance Sheet and Liquidity)
Net versus expectations: moderately positive. Investors were primed for an Investor Day, but not for a disclosed FY29 plan combining higher margins, near-doubled free cash flow, and a large authorization increase. The limitation is that these are non-GAAP, long-range targets with no GAAP reconciliation and depend on execution, construction demand, trade conditions, and successful integration—not a change to current-period guidance. (FY29 Financial Targets; Forward-Looking Statements)
Read the original 8-K on SEC EDGAR ↗